All Type of News
Antibiotics used by hospitals decline slightly in first half
The use of antibiotics in medical institutions inched down in the first half of this year, the Health Insurance Review and Assessment Service (HIRA) said Monday.
The HIRA said that hospitals and clinics prescribed ...
LGIS, Ildong to jointly develop hepatitis B drug
LG Life Sciences (LGLS) said Tuesday that it signed with Ildong Pharmaceutical to jointly develop a new hepatitis B drug ‘Besiforvir.’
According to LGLS which has completed the late-stage Phase II trial through its...
ENT still overprescribe antibiotics
Data released by the Health Insurance Review and Assessment Service (HIRA) on Monday shows that doctors in ENT department continue to overprescribe antibiotics.
The data said that the antibiotics prescription rate ...
Foreign products reliance makes Korean drug firms vulnerable
The government-mandated cuts in drug prices have prompted Korea’s leading drug maker to increase their dependence on foreign maker’s original drugs surge over the years.
Recent data from Yakup.com, a pharmaceutical...
Pharmaceutical firms pay 37 million won in annual salary on average
Most companies in the pharmaceutical sector are paying annual salaries near 37 million won to their new employees on average, statistics by on-line job portal Job Korea, Monday.
According to statistics, 572 enterpr...
Pharmaceutical salespeople in serious stress
The Ministry of Health and Welfare has launched a crackdown on unlawful drug marketing activities since August 2010. At that time, the ministry introduced a rule which slashes the price of a drug by up to 20 percent i...
Celgene Korea to negotiate Revlimid price
The National Health Insurance Corporation (NHIC) will decide Celgene’s cancer drug Revlimid to be put on the positive list and how much it will cost through negotiations with Celgene Korea, according to pharmaceutical...
Ferring’s inflammatory bowel disease drug approved
Ferring Pharmaceuticals Korea, the Korean subsidiary of European based Ferring BV, on Friday had its anti-inflammatory drug against Crohn’s disease approved.
The Korea Food and Drug Administration on Friday authori...
Drug makers betting on new combination products to tackle difficulties
Generic manufacturing has long been a major source of revenue for most Korean pharmaceutical firms. That heavy reliance and their weak overseas presence caused them to shirk from drug development as it costs huge amou...
5,175 drugs to be re-evaluated in 2013
The Korea Food and Drug Administration announced last Friday that a total of 5,175 products acting on nervous system will be re-evaluated next year as a regular program to assess their safety and efficacy.
The drug...
